Does AKEBIA THERAPEUTICS, INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores AKEBIA THERAPEUTICS, INC. (AKBA) 49.8 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 70, returns on capital 0, balance-sheet safety 100, capital discipline 44.

How has AKBA's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 49.8 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

AKEBIA THERAPEUTICS, INC.

AKBA · Healthcare · $355.7M mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power70

Median gross margin 64.7% over 8y, variable.

Returns on capital0

Median ROIC -115.6%, above the 9% hurdle in 0% of years.

Balance-sheet safety100

Net cash position — no leverage risk.

Capital discipline44

Owner earnings trend unclear, share count n/a.

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $1.34
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for AKBA yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale49.8 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — AKBA has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#113 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#111PODD INSULET CORPORATION50.1 out of 100, Shallow moatShallow moat
#112AUPH Aurinia Pharmaceuticals Inc.50.0 out of 100, Shallow moatShallow moat
#114ELSE Electro-Sensors, Inc.49.7 out of 100, Shallow moatShallow moat
#115OBIO Orchestra BioMed Holdings, Inc.49.7 out of 100, Shallow moatShallow moat

Compare AKBA with its nearest peers →All Healthcare companies on the Index →

Common questions about AKBA

Does AKEBIA THERAPEUTICS, INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores AKEBIA THERAPEUTICS, INC. (AKBA) 49.8 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 70, returns on capital 0, balance-sheet safety 100, capital discipline 44.
How has AKBA's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 49.8 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows AKBA’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/AKBA"
  width="340" height="150" style="border:0"
  title="AKBA Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell AKBA. See the disclaimer.